$AIMD
Ainos, Inc.

2017 Q1 Form 10-Q Financial Statement

#000101476317000005 Filed on May 12, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $185.0K $121.3K
YoY Change 52.55% 10.25%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $185.0K $121.3K
YoY Change 52.55% 10.25%
Operating Profit -$185.0K -$121.3K
YoY Change 52.55%
Interest Expense $3.959K $362.00
YoY Change 993.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$190.0K -$120.0K
YoY Change 58.33% 9.09%
Income Tax
% Of Pretax Income
Net Earnings -$189.0K -$121.6K
YoY Change 55.35% 10.58%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.13 -$0.09
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $260.0K
YoY Change -80.77% 8.33%
Cash & Equivalents $52.97K $264.2K
Short-Term Investments
Other Short-Term Assets $100.0K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $152.3K $270.0K
YoY Change -43.6% 12.5%
LONG-TERM ASSETS
Property, Plant & Equipment $39.91K $10.00K
YoY Change 299.1% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $195.9K $80.00K
YoY Change 144.84% -11.11%
TOTAL ASSETS
Total Short-Term Assets $152.3K $270.0K
Total Long-Term Assets $195.9K $80.00K
Total Assets $348.1K $350.0K
YoY Change -0.53% 6.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $170.0K
YoY Change -17.65% 112.5%
Accrued Expenses $10.00K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $790.0K $530.0K
YoY Change 49.06% 96.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.254M $690.0K
YoY Change 81.72% 91.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.254M $690.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.254M $690.0K
YoY Change 81.72% 46.81%
SHAREHOLDERS EQUITY
Retained Earnings -$1.456M
YoY Change
Common Stock $223.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$905.7K -$340.0K
YoY Change
Total Liabilities & Shareholders Equity $348.1K $350.0K
YoY Change -0.53% 6.06%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$189.0K -$121.6K
YoY Change 55.35% 10.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$126.5K $1.663K
YoY Change -7707.46% -102.38%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $10.00K
YoY Change 0.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.267K -$8.617K
YoY Change -38.88% -13.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.63K 250.0K
YoY Change -79.75%
NET CHANGE
Cash From Operating Activities -126.5K 1.663K
Cash From Investing Activities -5.267K -8.617K
Cash From Financing Activities 50.63K 250.0K
Net Change In Cash -81.15K 243.0K
YoY Change -133.39% -403.81%
FREE CASH FLOW
Cash From Operating Activities -$126.5K $1.663K
Capital Expenditures $10.00K $10.00K
Free Cash Flow -$136.5K -$8.337K
YoY Change 1537.42% -89.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Assets
Assets
348141
CY2016Q4 us-gaap Assets
Assets
462676
CY2017Q1 us-gaap Assets Current
AssetsCurrent
152269
CY2016Q4 us-gaap Assets Current
AssetsCurrent
262399
CY2016Q4 amar Customer Deposits Related Parties Current
CustomerDepositsRelatedPartiesCurrent
124833
CY2017Q1 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
791481
CY2016Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
791481
CY2016Q1 amar Amount Of Private Placement
AmountOfPrivatePlacement
937500
amar Amount Of Private Placement
AmountOfPrivatePlacement
1875000
CY2017Q1 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
26661574
CY2017Q1 amar Conversion Of Accounts Payable Related Party To Convertible Note Payable Related Party
ConversionOfAccountsPayableRelatedPartyToConvertibleNotePayableRelatedParty
CY2016Q1 amar Conversion Of Accounts Payable Related Party To Convertible Note Payable Related Party
ConversionOfAccountsPayableRelatedPartyToConvertibleNotePayableRelatedParty
144426
CY2017Q1 amar Customer Deposits Related Parties Current
CustomerDepositsRelatedPartiesCurrent
124833
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
142918
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
165502
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
326318
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
237540
CY2017Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basis of presentation.</div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> The accompanying financial statements, which should be read in conjunction with the financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> filed with the Securities and Exchange Commission, are unaudited, but have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> are not necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div></td> </tr> </table></div>
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52971
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21138
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264184
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-81154
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
243046
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22350935
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21916143
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22350935
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21916143
CY2017Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
270000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
223509
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
219161
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
CY2017Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
37835
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
37835
CY2017Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
187500
CY2016Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
187500
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
155962
CY2016Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
156063
CY2017Q1 us-gaap Gross Profit
GrossProfit
CY2016Q1 us-gaap Gross Profit
GrossProfit
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017Q1 us-gaap Interest Expense
InterestExpense
3959
CY2016Q1 us-gaap Interest Expense
InterestExpense
362
CY2017Q1 us-gaap Interest Paid
InterestPaid
CY2016Q1 us-gaap Interest Paid
InterestPaid
CY2017Q1 us-gaap Inventory Net
InventoryNet
CY2016Q4 us-gaap Inventory Net
InventoryNet
14700
CY2017Q1 us-gaap Liabilities
Liabilities
1253886
CY2016Q4 us-gaap Liabilities
Liabilities
1272575
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348141
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
462676
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1253886
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1272575
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50625
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5267
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8617
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126512
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1663
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-188972
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-121641
CY2017Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
185013
CY2016Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
121279
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-185013
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-121279
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5267
CY2016Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8617
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
61463
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
75739
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
CY2016Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
250000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39910
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44214
CY2017Q1 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
-7154
CY2016Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
-3259
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1455572
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1266600
CY2017Q1 us-gaap Revenues
Revenues
CY2016Q1 us-gaap Revenues
Revenues
CY2017Q1 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
CY2016Q1 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
185013
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
121279
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-905745
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-809899
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22277261
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20144810

Files In Submission

Name View Source Status
0001014763-17-000005-index-headers.html Edgar Link pending
0001014763-17-000005-index.html Edgar Link pending
0001014763-17-000005.txt Edgar Link pending
0001014763-17-000005-xbrl.zip Edgar Link pending
amar-20170331.xml Edgar Link completed
amar-20170331.xsd Edgar Link pending
amar-20170331_cal.xml Edgar Link unprocessable
amar-20170331_def.xml Edgar Link unprocessable
amar-20170331_lab.xml Edgar Link unprocessable
amar-20170331_pre.xml Edgar Link unprocessable
exhibit31-1a_03312017.htm Edgar Link pending
exhibit31-1b_03312017.htm Edgar Link pending
exhibit32-1_03312017.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q_03312017.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending